ADCETRIS® (brentuximab vedotin) - Official Patient Website
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)
ADCETRIS® for Classical Hodgkin Lymphoma
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)
ADCETRIS® (brentuximab vedotin) Study Results and Side Effects
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)
ADCETRIS® for Select Peripheral T-Cell Lymphomas
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)
Starting ADCETRIS® (brentuximab vedotin) Infusion Treatment
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)
ADCETRIS® for Diffuse Large B-Cell Lymphoma (DLBCL)
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)
ADCETRIS® (brentuximab vedotin) Cost and Resources
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)
ADCETRIS® for High-Risk Pediatric Classical Hodgkin Lymphoma
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)
Treatment considerations for classical Hodgkin lymphoma
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)
ADCETRIS® (brentuximab vedotin) Patient Stories
ADCETRIS is a prescription medicine directed against the CD30 protein. It is used to treat: Adults with previously untreated Stage 3 or 4 classical Hodgkin lymphoma, in combination with chemotherapy (Adriamycin, vinblastine, and dacarbazine)